Skip to main content
Skip to content
Info Menu
Show — Info Menu
Hide — Info Menu
Loading data...
Investors
Careers
Global locations
Mega Menu
Show — Mega Menu
Hide — Mega Menu
About Danaher
Approach
News
Science
Search
Mobile Top Menu
Show — Mobile Top Menu
Hide — Mobile Top Menu
Search
Mega Menu
Show — Mega Menu
Hide — Mega Menu
Who we are
About Us
Leadership
Our Businesses
What we stand for
Sustainability
DE+I
Our Process
Danaher Business System
Acquisitions
Partnership Initiatives
Mobile Mega Menu
Show — Mobile Mega Menu
Hide — Mobile Mega Menu
About Danaher
Who we are
About Us
Leadership
Our Businesses
What we stand for
Sustainability
DE+I
Approach
Column 1
Our Process
Danaher Business System
Column 2
Acquisitions
Partnership Initiatives
News
Science
Search
Mega Menu Mobile - Top Level
Show — Mega Menu Mobile - Top Level
Hide — Mega Menu Mobile - Top Level
About Danaher
Approach
News
Science
Search
Info Menu
Show — Info Menu
Hide — Info Menu
Loading data...
Investors
Careers
Global locations
Search
Clear
News
News Topic
Topic
Awards
Company
DE&I
Innovation
Partnerships
Sustainability
Sort by
Changed
Order
Ascending
Descending
Illuminating the future of genomic medicine
02.29.24
Organoids are small. Their future is big.
02.22.24
IDT’s Rolf Turk considers the future of CRISPR
02.08.24
Kaizen: Danaher's approach to global excellence
02.01.24
Combining mRNA Expertise to Better Fight Disease
11.22.23
Danaher, Innovative Genomics Institute join forces
01.09.24
Danaher's Eco-Friendly Packaging Breakthrough
12.01.23
Building a Sustainable Future
10.07.23
Leading the Way in the Golden Age of Biology
10.09.23
Danaher’s Evolutionary Story
10.08.23
See more
Press Releases